uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
24.93
-2.12 (-7.84%)
At close: May 18, 2026, 4:00 PM EDT
24.27
-0.66 (-2.65%)
Pre-market: May 19, 2026, 6:32 AM EDT
uniQure Employees
uniQure had 221 employees as of December 31, 2025. The number of employees increased by 12 or 5.74% compared to the previous year.
Employees
221
Change (1Y)
12
Growth (1Y)
5.74%
Revenue / Employee
$81,869
Profits / Employee
-$945,109
Market Cap
1.57B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 221 | 12 | 5.74% |
| Dec 31, 2024 | 209 | -271 | -56.46% |
| Dec 31, 2023 | 480 | -21 | -4.19% |
| Dec 31, 2022 | 501 | 38 | 8.21% |
| Dec 31, 2021 | 463 | 131 | 39.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Recursion Pharmaceuticals | 600 |
| Ardelyx | 489 |
| Nurix Therapeutics | 317 |
| Capricor Therapeutics | 231 |
| Monte Rosa Therapeutics | 187 |
| Innoviva | 159 |
| Inhibrx Biosciences | 110 |
QURE News
- 12 days ago - uniQure price target lowered to $50 from $70 at H.C. Wainwright - TheFly
- 13 days ago - uniQure price target raised to $28 from $14 at Stifel - TheFly
- 13 days ago - uniQure Earnings Call Transcript: Q1 2026 - Transcripts
- 13 days ago - uniQure Earnings release: Q1 2026 - Filings
- 13 days ago - uniQure Quarterly report: Q1 2026 - Filings
- 13 days ago - uniQure reports Q1 EPS (85c), consensus (75c) - TheFly
- 13 days ago - uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates - GlobeNewsWire
- 18 days ago - uniQure price target raised to $37 from $31 at Chardan - TheFly